With semaglutide (Wegovy), clinical trials showed that participants lost approximately 5% of their body weight by week 12, with maximum weight loss occurring around 60-68 weeks of treatment
What I actually see in our clinics The super responders The most striking thing I see on both medications is not the average its the super responders
With advanced diagnostics, expert guidance, and personalized dosing, this is not guesswork
(2019a)
Semaglutide, by stimulating the GLP-1 receptors in the brain, can lower food intake and create a sensation of fullness, resulting in long-term weight loss
In people with variants (SNPs) that limit GHC1, their BH4 levels werent able to rise enough to respond to inflammation.[ref] ( GCH1 gene in the genotype report section ) Interestingly, the researchers in the above study used vaccination as an acute model of systemic inflammation to determine how the GCH1 gene variant affected the increase (or lack thereof) of BH4 levels in the study participants